Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
08037 China Biotech Services
1.060
-0.050-4.50%
YOY
Do not show
Hide blank lines
(Q6)2022/06/30(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31
Assets
Current assets
Inventory
564.22% 13.66M -14.35% 4.74M -71.65% 2.06M 61.47% 5.53M
Accounts receivable
5.78% 252.15M 155.07% 105.94M 1059.01% 238.36M 108.8% 41.53M
Advance deposits and other receivables
24.54% 16.28M 1.51% 13.26M -15.17% 13.07M -18.13% 13.06M
Withholding and tax receivable
-- -- -- -- -97.94% 7K 11.8% 379K
Cash and equivalents
53.85% 204.88M -60.85% 150.55M 123.63% 133.17M 744.81% 384.54M
Derivative financial instruments-current assets
-- -- -- 1.53M -- -- -- --
Special items of current assets
-- -- 38.5% 1.76M -72.53% 1.27M -3.57% 1.27M
Total current assets
25.53% 486.98M -37.76% 277.77M 260.06% 387.94M 416.31% 446.31M
Non-current assets
Property, plant and equipment
-29.16% 78.53M -26.47% 94.71M 391.53% 110.84M 441.55% 128.8M
Interests in Joint Venture
-- 19.37M -- -- -- -- -- --
Derivative financial instruments-non-current assets
31.02% 2.8M -- -- -- 2.14M -- 5.64M
Intangible assets
-12.54% 73.7M -8.1% 80.94M -7.3% 84.26M -7.54% 88.07M
Goodwill
-2.42% 115.73M 2.52% 120.55M 2.82% 118.6M 1.95% 117.6M
Special items of non-current assets
8.45% 115.83M 12.83% 132.81M 7.4% 106.81M 22.92% 117.71M
Total non-current assets
-3.95% 405.95M -6.29% 429.01M 28.76% 422.65M 38.67% 457.81M
Total assets
10.16% 892.93M -21.83% 706.78M 85.92% 810.58M 117.03% 904.12M
Liabilities
Current liabilities
Accounts payable
-40.44% 111.98M -74.22% 54.93M 1082.71% 188M 1129.46% 213.04M
Notes payable
-- -- -- 38.65M -- -- -- --
Tax payable
101.29% 133.45M 136.58% 85.2M 41078.26% 66.3M 11516.45% 36.01M
Bank loans and overdrafts
-- -- 63.04% 17.39M -- -- -55.4% 10.66M
Other loans-current liabilities
130.63% 15.81M -- -- -22.24% 6.86M -- --
Financial lease liabilities-current liabilities
-7.66% 7.78M -39.86% 7.58M -19.74% 8.42M 73.26% 12.6M
Special items of current liabilities
-38.38% 23.66M -- 23.66M -- 38.39M -- --
Total current liabilities
-4.97% 292.67M -16.5% 227.4M 770.72% 307.97M 406.55% 272.31M
Net current assets
142.99% 194.3M -71.05% 50.38M 10.49% 79.96M 432.37% 174M
Total assets less current liabilities
19.43% 600.25M -24.12% 479.39M 25.46% 502.61M 74.14% 631.81M
Non-current liabilities
Financial lease liabilities-non-current liabilities
76.26% 8.05M -47.6% 3.56M -32.08% 4.57M 11.52% 6.79M
Deferred tax liability
-4.74% 9.67M -8.21% 9.94M -11.18% 10.15M -10.42% 10.83M
Convertible notes and bonds
-- 42.1M -- -- -- -- -- 76.29M
Special items of non-current liabilities
-- -- -- -- -17.56% 25.8M -17.56% 25.8M
Total non-current liabilities
47.63% 59.82M -88.73% 13.49M -67.95% 40.52M 142.01% 119.7M
Total liabilities
1.15% 352.49M -38.55% 240.89M 115.38% 348.49M 279.78% 392.02M
Total assets less total liabilities
16.95% 540.44M -9.02% 465.9M 68.53% 462.09M 63.42% 512.11M
Total equity and non-current liabilities
19.43% 600.25M -24.12% 479.39M 25.46% 502.61M 74.14% 631.81M
Equity
Share capital
-0.23% 96.32M -0.37% 96.32M -0.45% 96.54M -0.31% 96.69M
Other reserves
19.43% 330.62M 21.26% 299.08M 76.63% 276.84M 28.32% 246.65M
Shareholders' Equity
14.34% 426.95M 15.17% 395.4M 47.17% 373.39M 18.72% 343.33M
Non-controlling interest
27.94% 113.49M -58.23% 70.5M 333.31% 88.7M 598.25% 168.77M
Total equity
16.95% 540.44M -9.02% 465.9M 68.53% 462.09M 63.42% 512.11M
Total equity and total liabilities
10.16% 892.93M -21.83% 706.78M 85.92% 810.58M 117.03% 904.12M
Currency Unit
HKDHKDHKDHKD
Accounting Standards
HKASHKASHKASHKAS
Audit Opinions
--Unqualified Opinion--Unqualified Opinion
Auditor
--Luo Shenmei accounting firm--Luo Shenmei accounting firm

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
The main business of the Company is investment holding. The principal businesses of its subsidiaries are (I) providing medical laboratory testing services and health check-up services in Hong Kong, the PRC; (ii) providing tumor immunocytotherapy, immunocyte storage and health management services in the people's Republic of China (the "PRC"); (iii) manufacturing, R & D, sales and distribution of health related and pharmaceutical products in the PRC and Hong Kong, China; and (iv) providing insurance brokerage services.
CEO: Xiaolin Liu
Market: GEM
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...